Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Kalbasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2012 - 2016- University of Pennsylvania Health SystemInternship, Internal Medicine, 2011 - 2012
David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
CA State Medical License 2016 - 2026
PA State Medical License 2011 - 2016
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Start of enrollment: 2019 Nov 27
- Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma Start of enrollment: 2020 Oct 14
Publications & Presentations
PubMed
- Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response.Erik S Blomain, Shaghayegh Soudi, Ziwei Wang, Anish Somani, Ajay Subramanian
Cancer Research. 2025-03-14 - Association of Histologic Subtype With Radiation Response and Survival Outcomes in Synovial Sarcoma.Jennifer K Matsui, Scott Jackson, Judy Fang, David G Mohler, Robert J Steffner
Advances in Radiation Oncology. 2025-03-01 - Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum
The Lancet. Oncology. 2025-03-01
Press Mentions
Modified Salmonella Revs Immune Response, Combats Tumors in MiceFebruary 3rd, 2022- AACR Annual Meeting 2021: NextGen Stars Sessions Featured Research from Early-Career InvestigatorsMay 12th, 2021
- The First Spanish Immunotherapy Has Completed the Phase I Trial in Patients with Immunotherapy-Resistant CancerOctober 30th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
